Public Ventures LLC Completes First Public Company Financing as Broker-Distributor for Cue Biopharma, Inc. (Nasdaq: CUE)

DALLAS, TX/ACCESSWIRE/November 17, 2022/ Public Ventures, LLC, a wholly owned subsidiary of MDB Capital Holdings, LLCcompleted its first financing as a broker-dealer for Cue Biopharma, Inc. (NASDAQ: CUE).

The Public Ventures portion of the funding was completed through a private equity investment (PIPE) transaction with our community of experienced individual investors. Total funding for Cue Biopharma was approximately $30 million, with a significant portion coming from the public company community and institutional investors who had previously invested in Cue Biopharma. Full funding details are available at

“We are thrilled to close our first Public Ventures financing for an MDB Capital Group company co-founded over seven years ago with scientists at Albert Einstein College of Medicine,” said Christopher Marlett, CEO of MDB. Capital Holdings. “We are grateful to our community of member investors for enabling a value-added approach to financing visionary public companies that possess the potential to be market leaders in their technology category.”

About Public Ventures, LLC

Public Ventures is a member-driven investor community and broker clearing platform with a mission to support visionary public companies that have the potential to become market leaders in their technology category.

About MDB Capital Holdings, LLC

MDB was founded in 1997 with the goal of supporting visionary technology, inventors and tech entrepreneurs through a new form of public company that funds early-stage, pre-revenue companies through early public offerings, mostly listed on NASDAQ. After successfully launching 16 companies under this public company model, MDB is now able to increase the number of companies it can support through its unique process and community of investors.

MDB seeks to support the growth of the public venture capital market through its wholly owned subsidiaries Public Ventures, LLC (“Public Ventures”), PatentVest, Inc., and by incubating new visionary companies that go public through exclusively intended for MDB shareholders.

MDB is expanding the scope of Public Ventures, an SEC-registered broker and member of FINRA, to include self-clearing capabilities with a mission to create a value-added platform for investors and issuers.

For more information, please visit

Forward-looking statements

This press release contains “forward-looking statements”. These forward-looking statements are made as of the date they are first made and are based on current expectations, estimates, forecasts and projections as well as management’s beliefs and assumptions. Words such as “expect”, “anticipate”, “should”, “believe”, “hope”, “aim”, “project”, “goals”, “estimate”, “potential”, “predict” , “may”, “”, “could”, “could”, “intend”, “should” and variations of these terms or the negative form of these terms and similar expressions are intended to identify such forward-looking statements.

Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond MDB’s control. MDB’s actual results could differ materially from those indicated or implied by the forward-looking statements due to a number of factors, including, but not limited to, the risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent the views of MDB as of the date of this press release. MDB expects subsequent events and developments to change its views. MDB disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be taken to represent the views of MDB as of any date subsequent to the date of this press release.

Investor contacts

[email protected]

THE SOURCE: BMD Capital Holdings

About the author